Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Medicine

Memorial Sloan-Kettering Cancer Center

New York

NY 10021

USA

Name/email consistency: high

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. 2001 - 2003
Departments of Medicine, Epidemiology and Biostatistics, and Radiology, Memorial Sloan-Kettering Cancer Center, USA. 2002
Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. 1999

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma. Hwu, W.J., Krown, S.E., Menell, J.H., Panageas, K.S., Merrell, J., Lamb, L.A., Williams, L.J., Quinn, C.J., Foster, T., Chapman, P.B., Livingston, P.O., Wolchok, J.D., Houghton, A.N. J. Clin. Oncol. (2003) [Pubmed]
Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trial. Hwu, W.J., Krown, S.E., Panageas, K.S., Menell, J.H., Chapman, P.B., Livingston, P.O., Williams, L.J., Quinn, C.J., Houghton, A.N. J. Clin. Oncol. (2002) [Pubmed]
Treatment of metastatic melanoma in the brain with temozolomide and thalidomide. Hwu, W.J., Raizer, J., Panageas, K.S., Lis, E. Lancet Oncol. (2001) [Pubmed]
A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors. Hwu, W.J., Salem, R.R., Pollak, J., Rosenblatt, M., D'Andrea, E., Leffert, J.J., Faraone, S., Marsh, J.C., Pizzorno, G. Oncol. Res. (1999) [Pubmed]